Circa Group AS

Circa Group AS Current Assets

Delisted

The Current Assets of Circa Group AS (CIRCA.OL) as of Oct 23, 2026 is 13.61 M EUR. In the previous year, Current Assets was 36.05 M EUR — a change of -62.26% (lower).

Current Assets

13.61 MEUR

YoY

-62.26%

Last updated:

Current Assets of Circa Group AS is 2023 13.61 M EUR. Current Assets of Circa Group AS was 2022 36.05 M EUR. It decreases by -62.26% lower compared to the previous year.

The Circa Group AS Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2020
6.48 M EUR
Jan 1, 2021
46.02 M EUR
Jan 1, 2022
36.05 M EUR
Jan 1, 2023
13.61 M EUR
The Circa Group AS Current Assets history
YEARCurrent AssetsYoY
13.61 MEUR-62.26%
36.05 MEUR-21.67%
46.02 MEUR+609.91%
6.48 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Circa Group AS Stock analysis

What does Circa Group AS do? Circa Group AS produces biochemicals through its proprietary Furacell process, converting biomass into advanced bio-based chemicals. The company's product portfolio includes Cyrene, a bio-solvent derived from Levoglucosenone (LGO), which serves as a greener alternative to traditional toxic solvents in paints, coatings, battery, and textile applications. The company develops flavorings, biopolymers, and bio-solvents under development, with Cyrene being a key product for industrial processes requiring safer solvents. Subsidiaries such as Circa Sustainable Chemicals Pty Ltd, Circa Sustainable Chemicals SAS, Circa Sustainable Chemicals BV, and Circa Group Pty. Ltd. support the company's global operations. Circa Group AS sells its biochemical products primarily to industries requiring sustainable chemical solutions, including paint and coating manufacturers, battery producers, and textile companies. The company's focus on eco-friendly solvents like Cyrene targets markets seeking safer alternatives to conventional toxic solvents. By leveraging its Furacell process, Circa Group AS differentiates its offerings as advanced bio-based chemicals with improved environmental and performance profiles. The company's revenue streams are derived from the sale of its biochemical products, particularly Cyrene and other bio-solvents, to industrial clients across multiple sectors. Its subsidiaries facilitate regional market access and operational efficiency, supporting the commercialization of its proprietary technology. As a biotechnology firm, Circa Group AS monetizes its proprietary Furacell process by converting biomass into high-demand sustainable chemicals. Circa Group AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Circa Group AS stock

Current Assets of Circa Group AS is 13.61 M EUR in 2023.

Current Assets of Circa Group AS changed from 36.05 M EUR to 13.61 M EUR, representing a -62.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Circa Group AS since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Circa Group AS historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Circa Group AS

All Key Metrics — Circa Group AS